Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intrinsic capacity and frailty in older adults with end-stage kidney disease undergoing pre-kidney transplant comprehensive geriatric assessment.
Collette-Robert S, Guerville F, Novais T, Pongan E, Morelon E, Vernaudon J, Francq E, Couzi L, Bourdel-Marchasson I, Caillard S, Pszczolinski R, Heitz D, Gilbert T, Garnier-Crussard A. Collette-Robert S, et al. Among authors: pszczolinski r. J Nutr Health Aging. 2024 Apr 20;28(6):100236. doi: 10.1016/j.jnha.2024.100236. Online ahead of print. J Nutr Health Aging. 2024. PMID: 38643611 Free article.
Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients.
Benotmane I, Olagne J, Gautier-Vargas G, Cognard N, Heibel F, Braun-Parvez L, Keller N, Martzloff J, Perrin P, Pszczolinski R, Moulin B, Fafi-Kremer S, Caillard S. Benotmane I, et al. Among authors: pszczolinski r. Transplantation. 2023 Aug 1;107(8):e215-e218. doi: 10.1097/TP.0000000000004655. Epub 2023 Jul 20. Transplantation. 2023. PMID: 37340538 Free PMC article. No abstract available.
A rapid decline in the anti-receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration.
Benotmane I, Velay A, Vargas GG, Olagne J, Cognard N, Heibel F, Braun-Parvez L, Martzloff J, Perrin P, Pszczolinski R, Moulin B, Fafi-Kremer S, Caillard S. Benotmane I, et al. Among authors: pszczolinski r. Kidney Int. 2022 Nov;102(5):1188-1190. doi: 10.1016/j.kint.2022.07.022. Epub 2022 Aug 13. Kidney Int. 2022. PMID: 35973595 Free PMC article. No abstract available.
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.
Benotmane I, Gautier-Vargas G, Cognard N, Olagne J, Heibel F, Braun-Parvez L, Martzloff J, Perrin P, Pszczolinski R, Moulin B, Fafi-Kremer S, Caillard S. Benotmane I, et al. Among authors: pszczolinski r. J Pers Med. 2022 Jul 5;12(7):1107. doi: 10.3390/jpm12071107. J Pers Med. 2022. PMID: 35887604 Free PMC article.
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients.
Benotmane I, Velay A, Gautier-Vargas G, Olagne J, Obrecht A, Cognard N, Heibel F, Braun-Parvez L, Keller N, Martzloff J, Perrin P, Pszczolinski R, Moulin B, Fafi-Kremer S, Thaunat O, Caillard S. Benotmane I, et al. Among authors: pszczolinski r. Am J Transplant. 2022 Nov;22(11):2675-2681. doi: 10.1111/ajt.17121. Epub 2022 Jun 30. Am J Transplant. 2022. PMID: 35713984 Free PMC article.